December 2010
Volume 51, Issue 12
Free
Letters to the Editor  |   December 2010
Author Response: The Effect of Bevacizumab on Human Tenon Fibroblasts in Ocular Wound Healing
Author Affiliations & Notes
  • Evelyn O'Neill
    Centre for Eye Research Australia, Melbourne Victoria, Australia.
Investigative Ophthalmology & Visual Science December 2010, Vol.51, 6904. doi:10.1167/iovs.10-6480
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Evelyn O'Neill; Author Response: The Effect of Bevacizumab on Human Tenon Fibroblasts in Ocular Wound Healing. Invest. Ophthalmol. Vis. Sci. 2010;51(12):6904. doi: 10.1167/iovs.10-6480.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
I would like to thank Drs. Van Bergen and Stalmans for their recent letter regarding our manuscript published online June 23, 2010, “Antifibrotic Activity of Bevacizumab on Human Tenon's Fibroblasts in Vitro.” 
On behalf of my co-authors, I apologize for the inadvertent error made when quoting her work and would like to assure her that the same was amended before publication of the article, so that the sentence in the uncorrected proof that read:
 

Li et al.39 found a single dose of 7.5 mg bevacizumab (0.03 mL of 25 mg/mL) given immediately after surgery significantly reduced the density of blood vessels and the number of inflammatory cells during the early stages of wound healing and reduced the collagen deposition in the later stages.

was changed to:
 

Li et al.39 found a single dose of 7.5 mg bevacizumab (0.3 mL of 25 mg/mL) given immediately after surgery significantly reduced the density of blood vessels during the early stages of wound healing and reduced the collagen deposition in the later stages.

 
Again, thanks to Drs. van Bergen and Stalmans for their letter and for bringing the error to our attention. 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×